Literature DB >> 21172290

IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.

Andrea Cassinotti1, Satish Keshav, Sandro Ardizzone, Neil Mortensen, Gianluca Sampietro, Paolo Fociani, Piergiorgio Duca, Bruce George, Marco Lazzaroni, Gianpiero Manes, Brian Warren, Diego Foschi, Gianluca Vago, Gabriele Bianchi Porro, Simon Travis.   

Abstract

BACKGROUND AND AIMS: The National UK IBD audit tool is an electronic database created to improve the quality and safety of care for IBD patients by auditing individual patient care, service resources and organisation against national standards. We used the National UK IBD audit tool to compare the organisation and process of IBD care between services in Oxford (UK) and Milan (Italy), as a pilot study to evaluate its application outside national boundaries.
METHODS: Clinical and demographic data of patients with CD and UC, consecutively admitted during a 2month period, were collected and compared between the centres, to each other and to the UK IBD standards obtained by previous audit analyses performed in Oxford in 2006.
RESULTS: 20 and 26 patients with UC were admitted in Oxford and Milan, as well as 21 and 20 patients with CD, respectively. Most admissions in Milan were planned admissions for moderately active treatment-refractory disease. No patient died. Oxford had a higher surgery rate. Endoscopy for UC consisted mainly of colonoscopy in Milan (92%) and flexible sigmoidoscopy in Oxford (64%). In CD, Oxford data revealed a higher use of immununomodulators and CT scan, compared with higher use of bowel ultrasound in Milan. CRP was the preferred biomarker of disease activity. The following areas did not reach the standards set for the 2006 UK IBD Audit: the lack in Milan of IBD specialist nurses and few dietitian visits, as well as little attention to heparin prophylaxis and abdominal radiography in UC. Both sites paid little attention to stool cultures and revealed a high rate of active smokers in CD and little attention to bone protection in steroids users. Since the 2006 audit in Oxford, improvements include IBD specialist nurse visits, dietitian visits, number of active smokers, stool samples, prophylactic heparin, bone protection and nutritional assessment.
CONCLUSIONS: Consistent procedural differences between Oxford and Milan identified by audits of both UC and CD could be resolved by organisational change, with an improvement in the service. The UK IBD audit tool is an easy instrument to assess the processes and outcomes of care delivery in IBD and can be applied also outside UK.

Entities:  

Year:  2009        PMID: 21172290     DOI: 10.1016/j.crohns.2009.08.002

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

1.  Defining the optimal design of the inflammatory bowel disease multidisciplinary team: results from a multicentre qualitative expert-based study.

Authors:  Pritesh Morar; Jamie Read; Sonal Arora; Ailsa Hart; Janindra Warusavitarne; James Green; Nick Sevdalis; Cathryn Edwards; Omar Faiz
Journal:  Frontline Gastroenterol       Date:  2015-03-26

2.  Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.

Authors:  Subrata Ghosh; Brian Bressler; Jill Petkau; Roopal B Thakkar; Song Wang; Martha Skup; Jingdong Chao; Remo Panaccione; Stefan Schreiber
Journal:  Dig Dis Sci       Date:  2019-01-19       Impact factor: 3.199

Review 3.  Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Authors:  Gerda C Leitner; Harald Vogelsang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

4.  Influence of dietary isoflavone intake on gastrointestinal symptoms in ulcerative colitis individuals in remission.

Authors:  Dominika Głąbska; Dominika Guzek; Dominika Grudzińska; Gustaw Lech
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

5.  Lycopene, Lutein and Zeaxanthin May Reduce Faecal Blood, Mucus and Pus but not Abdominal Pain in Individuals with Ulcerative Colitis.

Authors:  Dominika Głąbska; Dominika Guzek; Paulina Zakrzewska; Dariusz Włodarek; Gustaw Lech
Journal:  Nutrients       Date:  2016-09-30       Impact factor: 5.717

6.  Impact of therapeutic drug level monitoring on outcomes of patients with Crohn's disease treated with Infliximab: real world data from a retrospective single centre cohort study.

Authors:  Nikolaos Kamperidis; Paul Middleton; Tracey Tyrrell; Ioannis Stasinos; Naila Arebi
Journal:  Frontline Gastroenterol       Date:  2019-02-01

7.  Establishing the aims, format and function for multidisciplinary team-driven care within an inflammatory bowel disease service: a multicentre qualitative specialist-based consensus study.

Authors:  Pritesh S Morar; Nick Sevdalis; Janindra Warusavitarne; Ailsa Hart; James Green; Cathryn Edwards; Omar Faiz
Journal:  Frontline Gastroenterol       Date:  2017-08-10

8.  Variation in Provider Connectedness Associates With Outcomes of Inflammatory Bowel Diseases in an Analysis of Data From a National Health System.

Authors:  Shirley Cohen-Mekelburg; Xianshi Yu; Deena Costa; Timothy P Hofer; Sarah Krein; John Hollingsworth; Wyndy Wiitala; Sameer Saini; Ji Zhu; Akbar Waljee
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-13       Impact factor: 13.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.